« Back to Record
Maher, T. T., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. S., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., Molenberghs, G., Penninckx, B., Randall, M. M., Van Den Blink, B., Fieuw, A., Vandenrijn, C., Rocak, S., Seghers, I., Shao, L., Taneja, A., Jentsch, G., Watkins, T. R., Wuyts, W., Kreuter, M., Verbruggen, N., Prasad, N., Wijsenbeek, M. S., & Bondue, B. (2023). Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials. JAMA (Chicago, Ill.), 329(18), 1567-1578. doi:10.1001/jama.2023.5355
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/360009



